A panel of experts in achondroplasia discuss the importance of establishing a multidisciplinary care team of specialists during the prenatal and newborn period to provide diagnosis, management, and counseling to patients with achondroplasia and their families. - - - - - Faculty: Andrew Dauber, MD, MMSc Faculty: Nadia Merchant, MD Faculty: Alireza A. Shamshirsaz, MD - - - - - Supported by an independent educational grant from BioMarin. Developed through a strategic collaboration between the Society for Maternal-Fetal Medicine and Medscape.
Medscape
Health, Wellness & Fitness
New York, NY 125,875 followers
The leading online global destination for physicians and healthcare professionals: https://wb.md/2EPrMgZ
About us
Our Mission: To improve patient care with comprehensive clinical information and resources essential to physicians and healthcare professionals. Our Company: Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME. Medscape has over 30 distinct specialty sites for physicians, plus sites for nurses, pharmacists, dentists, and medical students. All content on Medscape.com and Medscape.org is available for free.
- Website
-
http://www.medscape.com
External link for Medscape
- Industry
- Health, Wellness & Fitness
- Company size
- 501-1,000 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 1995
- Specialties
- medical news, medical reference, and continuing medical education
Locations
-
Primary
395 Hudson Street
New York, NY 10014, US
Employees at Medscape
Updates
-
Just how much *do* you know about #JAKinhibitors for #UlcerativeColitis? Watch this clinical conversation w/ @DCharabaty to learn about risk/benefits and how to initiate for the right candidates. ✅ Click to Start: http://ms.spr.ly/6041lktJL
-
Get the latest from ASCO 2024! 🎤 Conceptualize the new and emerging data related to HER2-targeted therapies and stay abreast of evolving areas of interest for therapies. Right this way! 🕺 http://ms.spr.ly/6046lrmsg #MedTwitter
-
🎗️ Impact patient care with fresh insights from Perspectives in Breast Cancer! Meet us in Washington DC Sept 6-7: http://ms.spr.ly/6046lnCdM. Gain CME/CE credit and invaluable new information about diagnosing and treating HR+, #HER2, #TNBC #brca #bcsm #PBCClive24
-
🚨 SAVE THE DATE! #PsychUpdate25 is coming 📆 March 20-22 in📍 Chicago. Dive into the latest in #psychiatry with top experts. Missed this year? Secure your spot early with code 2025PSYCH for 30% off! 🔏 Register now: http://ms.spr.ly/6047lnCbv
-
💡 Discover the latest in acute leukemia and myelodysplasia at the Acute Leukemia Forum! Engage with world-renowned experts and explore pioneering research. Elevate your care and join our healing community. A must-attend event! 🧬 Click here: http://ms.spr.ly/6044lnCrn #ALFlive25
-
🚨 ALERT: Use code "CINCINNATI" for 30% off the Psychopharmacology Update. 📚 Immerse yourself in the newest psychiatric treatments & research. Expert faculty, groundbreaking knowledge. Transform your approach! Click here to 🔒 in the rate: http://ms.spr.ly/6044lHN1a #PsychPharm24
-
💡 Test yourself on the use of domain-based approaches for choosing the best #PsoriaticArthritis treatment for your patients. Find out if a #JAKinhibitor is right! http://ms.spr.ly/6042lrW0j | #RheumTwitter #CME #MedEd
-
Learn to use these key data points in clinic to make sense of the evidence, efficacy, and safety of #JAKinhibitors for immunological conditions, like X, Y, Z. Watch Now ➡️ http://ms.spr.ly/6048lrWww
-
🎥 WATCH: Unlocking ASCO 2024 Our latest Medscape Masters live event covered groundbreaking research and clinical trials that have the potential to transform cancer treatment protocols. Highlights include: · ESOPEC Trial Results · CROWN Trial Findings · Advancements in Breast Cancer Treatment · NADINA Trial Insights Catch the replay here ➡️ http://ms.spr.ly/6048lnvGM #ASCO2024 #CancerResearch #Oncology